{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:06:00Z","timestamp":1788303960648,"version":"build-2803163510"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1093\/brain\/awm316","type":"journal-article","created":{"date-parts":[[2008,1,9]],"date-time":"2008-01-09T20:26:03Z","timestamp":1199910363000},"page":"1197-1208","source":"Crossref","is-referenced-by-count":206,"title":["Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model"],"prefix":"10.1093","volume":"131","author":[{"given":"Susan K.","family":"Halstead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke M. P.","family":"Zitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Greenshields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart C.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell P.","family":"Rother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Plomp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,1,9]]},"reference":[{"key":"key\n\t\t\t\t20170508031921_B1","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1128\/IAI.70.9.5008-5018.2002","article-title":"Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barre syndrome","volume":"70","author":"Bowes","year":"2002","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170508031921_B2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(95)12155-2","article-title":"Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice","volume":"201","author":"Buchwald","year":"1995","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508031921_B3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.nbd.2007.07.008","article-title":"Anti-ganglioside antibodies alter presynaptic release and calcium influx","volume":"28","author":"Buchwald","year":"2007","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170508031921_B4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/1097-4598(200007)23:7<1035::AID-MUS5>3.0.CO;2-R","article-title":"Anti-GQ1b antibodies and evoked acetylcholine release at mouse motor endplates","volume":"23","author":"Bullens","year":"2000","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170508031921_B5","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1523\/JNEUROSCI.22-16-06876.2002","article-title":"Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function","volume":"22","author":"Bullens","year":"2002","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B6","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1212\/WNL.43.10.1911","article-title":"Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies","volume":"43","author":"Chiba","year":"1993","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508031921_B7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0161-5890(95)00135-2","article-title":"Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity","volume":"33","author":"Ebanks","year":"1996","journal-title":"Mol Immunol"},{"key":"key\n\t\t\t\t20170508031921_B8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Fisher","year":"1956","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508031921_B9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","article-title":"Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations","volume":"104","author":"Goodyear","year":"1999","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170508031921_B10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508031921_B11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ana.20546","article-title":"Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome","volume":"58","author":"Halstead","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508031921_B12","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh231","article-title":"Anti-disialoside antibodies kill perisynaptic schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy","volume":"127","author":"Halstead","year":"2004","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508031921_B13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.37.6.1006","article-title":"Guillain-Barre syndrome: activated complement components C3a and C5a in CSF","volume":"37","author":"Hartung","year":"1987","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508031921_B14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.2007.06554.x","article-title":"Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria","volume":"137","author":"Hill","year":"2007","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20170508031921_B15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508031921_B16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170508031921_B17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mus.10060","article-title":"Detection and prevalence of alpha-latrotoxin-like effects of serum from patients with Guillain-Barre syndrome","volume":"25","author":"Jacobs","year":"2002","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170508031921_B18","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/brain\/awg235","article-title":"Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding","volume":"126","author":"Jacobs","year":"2003","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508031921_B19","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1111\/j.1460-9568.2007.05438.x","article-title":"Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse rolling Nagoya","volume":"25","author":"Kaja","year":"2007","journal-title":"Eur J Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.expneurol.2006.06.003","article-title":"Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia","volume":"202","author":"Kaminski","year":"2006","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170508031921_B21","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1172\/JCI113231","article-title":"Activation of terminal components of complement in patients with Guillain-Barre syndrome and other demyelinating neuropathies","volume":"80","author":"Koski","year":"1987","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170508031921_B22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mus.20544","article-title":"Single-fiber electromyography shows terminal axon dysfunction in Miller Fisher syndrome: a case report","volume":"34","author":"Lange","year":"2006","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170508031921_B23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-2236(85)90064-5","article-title":"Gangliosides of the neuron","volume":"8","author":"Ledeen","year":"1985","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model","volume":"27","author":"Lehmann","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B25","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI0216086","article-title":"Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection","volume":"110","author":"Lin","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170508031921_B26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/01.wnl.0000191400.77080.21","article-title":"Presynaptic neuromuscular transmission defect in the Miller Fisher syndrome","volume":"66","author":"Lo","year":"2006","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508031921_B27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000463082","article-title":"Mechanisms of tissue damage by the membrane attack complex of complement","volume":"6","author":"Morgan","year":"1989","journal-title":"Complement Inflamm"},{"key":"key\n\t\t\t\t20170508031921_B28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2006.03205.x","article-title":"The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice","volume":"146","author":"Morgan","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20170508031921_B29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/brain\/124.5.893","article-title":"Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal","volume":"124","author":"O\u2019Hanlon","year":"2001","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508031921_B30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(01)00373-3","article-title":"IgM monoclonal antibody against terminal moiety of GM2, GalNAc-GD1a and GalNAc-GM1b from a pure motor chronic demyelinating polyneuropathy patient: effects on neurotransmitter release","volume":"119","author":"Ortiz","year":"2001","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170508031921_B31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1531-8249(199902)45:2<189::AID-ANA9>3.0.CO;2-T","article-title":"Miller Fisher anti-GQ1b antibodies: a-latrotoxin-like effects on motor end plates","volume":"45","author":"Plomp","year":"1999","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508031921_B32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-510X(99)00328-7","article-title":"Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain-Barre syndrome","volume":"174","author":"Putzu","year":"2000","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508031921_B33","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1523\/JNEUROSCI.5623-06.2007","article-title":"The membrane attack complex of the complement system is essential for rapid Wallerian degeneration","volume":"27","author":"Ramaglia","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B34","first-page":"369","article-title":"The interchangeability of the complement components of different animal species; literature survey","volume":"14","author":"Rice","year":"1950","journal-title":"Can J Comp Med Vet Sci"},{"key":"key\n\t\t\t\t20170508031921_B35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(94)92694-8","article-title":"Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release","volume":"343","author":"Roberts","year":"1994","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170508031921_B36","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.4049\/jimmunol.136.12.4456","article-title":"Activated terminal complement in cerebrospinal fluid in Guillain-Barre syndrome and multiple sclerosis","volume":"136","author":"Sanders","year":"1986","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170508031921_B37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.20403","article-title":"Changes in the neuromuscular synapse induced by an antibody against gangliosides","volume":"57","author":"Santafe","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508031921_B38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10072-005-0445-2","article-title":"Electrophysiological evidence by single fibre electromyography of neuromuscular transmission impairment in a case of Miller Fisher syndrome","volume":"26","author":"Sartucci","year":"2005","journal-title":"Neurol Sci"},{"key":"key\n\t\t\t\t20170508031921_B39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4157(96)00011-1","article-title":"The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies","volume":"1286","author":"Schwarz","year":"1996","journal-title":"Biochim Biophys Acta - Reviews on Biomembranes"},{"key":"key\n\t\t\t\t20170508031921_B40","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"27","author":"Susuki","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508031921_B41","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol Immunol"},{"key":"key\n\t\t\t\t20170508031921_B42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<640::AID-MUS14>3.0.CO;2-#","article-title":"Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block","volume":"22","author":"Uncini","year":"1999","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170508031921_B43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170508031921_B44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-5728(99)00213-1","article-title":"The immunopathogenesis of Miller Fisher syndrome","volume":"100","author":"Willison","year":"1999","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170508031921_B45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0165-5728(94)90042-6","article-title":"Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome","volume":"50","author":"Willison","year":"1994","journal-title":"J Neuroimmunol"},{"key":"key\n\t\t\t\t20170508031921_B46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0960-8966(01)00296-6","article-title":"Presynaptic neuromuscular transmission block in Guillain-Barre syndrome associated with anti-GQ1b antibodies","volume":"12","author":"Wirguin","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170508031921_B47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/131\/5\/1197\/16695076\/awm316.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T15:28:07Z","timestamp":1684164487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awm316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,9]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,1,9]]},"published-print":{"date-parts":[[2008,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awm316","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1108194.564200","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,9]]}}}